Literature DB >> 10831280

Structure-activity studies on gossypol in tumor cell lines.

M D Shelley1, L Hartley, P W Groundwater, R G Fish.   

Abstract

Gossypol [(2,2'-binaphthalene)-8,8'-dicarboxaldehyde-1,1',6,6',7,7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl] 1a is a naturally occurring compound extracted from the cotton plant and has been extensively studied as an oral male contraceptive. Its favorable toxicity profile, and the more recent demonstration of anti-tumor activity in animals and humans, prompted us to investigate the role of the aldehyde groups in a structure-activity study in cultured tumor cells. Four racemic compounds were evaluated: gossypol 1a, gossypolone 2, the bis Schiff's base of L-phenylalanine methyl ester with gossypol (bis Schiff's base) 1c and apogossypol 1b. The former two compounds both retain the aldehyde functional groups at positions 8 and 8' of the molecule whilst in the latter two compounds the aldehydes are blocked or absent, respectively. In addition, the l- and d-isomers of gossypol 1a, the bis Schiff's base 1c and the half Schiff's base 1d (one aldehyde blocked) were tested. The cell lines studied included melanoma (SK-mel-19), cervix (Sihas), small cell lung (H69) and myelogenous leukemia (K562). Cytotoxicity was measured using the MTT and flow cytometric viability assays. Racemic gossypol 1a and gossypolone 2 induced similar dose-dependent decreases in cell viability in all the cell lines with IC50 values of 23-46 and 28-50 microM, respectively. In contrast, the racemic bis Schiff's base derivative of gossypol 1c and apogossypol 1b showed minimal activity in any cell line up to 50 microM. The l-enantiomer of gossypol 1a was significantly more active than the d-enantiomer (IC50 of 20 versus > 50 microM, respectively). When one aldehyde of either enantiomer was blocked 1d cytoxicity was comparable to the l-enantiomer of gossypol. The data suggest that only one aldehyde group is required for the cytotoxicity of gossypol 1a, irrespective of the stereoconfiguration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10831280     DOI: 10.1097/00001813-200003000-00009

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  13 in total

Review 1.  The conduct of drug metabolism studies considered good practice (I): analytical systems and in vivo studies.

Authors:  Xiaodong Liu; Lee Jia
Journal:  Curr Drug Metab       Date:  2007-12       Impact factor: 3.731

2.  Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins.

Authors:  Jun Wei; Shinichi Kitada; Michele F Rega; Aras Emdadi; Hongbin Yuan; Jason Cellitti; John L Stebbins; Dayong Zhai; Jiazhi Sun; Li Yang; Russell Dahl; Ziming Zhang; Bainan Wu; Si Wang; Tyler A Reed; Hong-Gang Wang; Nicholas Lawrence; Said Sebti; John C Reed; Maurizio Pellecchia
Journal:  Mol Cancer Ther       Date:  2009-04       Impact factor: 6.261

Review 3.  Why anti-Bcl-2 clinical trials fail: a solution.

Authors:  Y Harazono; K Nakajima; A Raz
Journal:  Cancer Metastasis Rev       Date:  2014-03       Impact factor: 9.264

Review 4.  Alkynoates as Versatile and Powerful Chemical Tools for the Rapid Assembly of Diverse Heterocycles under Transition-Metal Catalysis: Recent Developments and Challenges.

Authors:  Imtiaz Khan; Aliya Ibrar; Sumera Zaib
Journal:  Top Curr Chem (Cham)       Date:  2021-01-05

5.  Gossypol with Hydrophobic Linear Esters Exhibits Enhanced Antitumor Activity as an Inhibitor of Antiapoptotic Proteins.

Authors:  Yuzhi Lu; Shuangchan Wu; Yuan Yue; Si He; Jun Li; Jun Tang; Wei Wang; Hai-Bing Zhou
Journal:  ACS Med Chem Lett       Date:  2016-10-19       Impact factor: 4.345

6.  Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivo.

Authors:  Yuan Sun; Jack Wu; Amro Aboukameel; Sanjeev Banerjee; Alan A Arnold; Jianyong Chen; Zaneta Nikolovska-Coleska; Yanqiong Lin; Xiaolan Ling; Dajun Yang; Shaomeng Wang; Ayad Al-Katib; Ramzi M Mohammad
Journal:  Cancer Biol Ther       Date:  2008-09-04       Impact factor: 4.742

7.  Apogossypolone (ApoG2) induces ROS-dependent apoptosis and reduces invasiveness of PC12 cells in vitro and in vivo.

Authors:  Dengqiang Lin; Xiaoxia Li; Lieyu Xu; Jianpo Lian; Yunze Xu; Li Meng; Xin Xie; Xiaojing Wang; Hongchao He; Danfeng Xu; Chenghe Wang; Yu Zhu
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

8.  Inhibitory activity of apogossypol in human prostate cancer in vitro and in vivo.

Authors:  Wenhua Zhan; Xingbin Hu; Jing Yi; Qunxing An; Xiaofeng Huang
Journal:  Mol Med Rep       Date:  2015-02-10       Impact factor: 2.952

9.  Evaluation of anticancer properties of a decoction containing Adenanthera pavonina L. and Thespesia populnea L.

Authors:  Indeewari K S Lindamulage; Preethi Soysa
Journal:  BMC Complement Altern Med       Date:  2016-02-20       Impact factor: 3.659

10.  AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis.

Authors:  Shuraila F Zerp; Rianne Stoter; Gitta Kuipers; Dajun Yang; Marc E Lippman; Wim J van Blitterswijk; Harry Bartelink; Rogier Rooswinkel; Vincent Lafleur; Marcel Verheij
Journal:  Radiat Oncol       Date:  2009-10-23       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.